Alex Schriver
Alex Schriver is a prominent figure in the pharmaceutical industry, serving as a spokesperson for the Pharmaceutical Research and Manufacturers of America (PhRMA). He is known for advocating against government price controls on medications, arguing that such policies could stifle innovation and reduce the availability of new treatments for patients. Recently, he made headlines by publicly opposing President Donald Trump's decree aimed at significantly lowering drug prices, stating that it would be detrimental to American patients and the overall healthcare system.
Not in the pool (under ¢1).
Recent news mentions
Alex Schriver, senior vice president at the Pharmaceutical Research and Manufacturers of America, known as PhRMA, said in a statement that tariffs risk those plans because every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing.
Pharmaceutical tariffs: A 100% tariff on some imported drugs is coming October 1, Trump says
United States· 2025-09-26
Alex Schriver, a PhRMA spokesperson, warned against implementing a 'Most Favored Nation' policy.
Trump’s next plan to lower US drug prices: Raise them in other countriesUnited States· 2025-09-12
Alex Schriver, senior vice president at PhRMA, said in a statement that truthful and non-misleading DTC advertising is protected under the First Amendment.
Trump signs order looking to decrease number of drug ads on TV and on social mediaUnited States· 2025-09-10
PhRMA senior vice-president Alex Schriver said in a statement that policymakers should rein in health care middlemen driving up costs for Americans.
Trump demands drug companies lower prices in U.S. and raise them in other countries
Canada· 2025-08-01
Alex Schriver, spokesman for industry group PhRMA, expressed concerns that tariffs could increase the chance of shortages.
Trump planning U.S. tariffs on drugs, semiconductor chipsCanada· 2025-07-08Alex Schriver stated that government price fixing is harmful to American patients.
Trump decreta una rebaja de hasta el 80% en los medicamentos y exige a las farmacéuticas que los suban en el extranjero | Internacional
Spain· 2025-05-12